Current and future therapeutical approaches for COVID-19.


Journal

Drug discovery today
ISSN: 1878-5832
Titre abrégé: Drug Discov Today
Pays: England
ID NLM: 9604391

Informations de publication

Date de publication:
08 2020
Historique:
received: 01 05 2020
revised: 20 05 2020
accepted: 16 06 2020
pubmed: 24 6 2020
medline: 1 9 2020
entrez: 24 6 2020
Statut: ppublish

Résumé

We review the evolution of our clinical understanding of COVID-19, possible therapeutic targets, and prospects for COVID-19 management.

Identifiants

pubmed: 32574697
pii: S1359-6446(20)30246-4
doi: 10.1016/j.drudis.2020.06.018
pmc: PMC7305909
pii:
doi:

Substances chimiques

Antiviral Agents 0
Viral Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1545-1552

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
PLoS Med. 2006 Sep;3(9):e343
pubmed: 16968120
Drug Discov Today. 2020 May;25(5):810-812
pubmed: 32198066
Thorax. 2004 Mar;59(3):252-6
pubmed: 14985565
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Antiviral Res. 2013 Nov;100(2):446-54
pubmed: 24084488
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Am J Epidemiol. 2004 Feb 1;159(3):229-31
pubmed: 14742282
Radiology. 2020 Aug;296(2):E41-E45
pubmed: 32049601
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Emerg Microbes Infect. 2020 Dec;9(1):382-385
pubmed: 32065055
J Cell Physiol. 2020 Dec;235(12):9133-9142
pubmed: 32394467
Antiviral Res. 2014 Jul;107:84-94
pubmed: 24769245
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
Clin Rev Allergy Immunol. 2019 Jun;56(3):308-321
pubmed: 28963611
Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6
pubmed: 15616839
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Br J Clin Pharmacol. 2011 Oct;72(4):634-46
pubmed: 21649691
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Lancet. 2020 Feb 29;395(10225):683-684
pubmed: 32122468
Future Med Chem. 2010 Jun;2(6):923-8
pubmed: 21426110
Biosci Trends. 2020 Mar 16;14(1):72-73
pubmed: 32074550
Nat Rev Drug Discov. 2016 May;15(5):327-47
pubmed: 26868298
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Science. 2009 Aug 28;325(5944):1131-4
pubmed: 19628819
Pharmacol Ther. 2015 Nov;155:11-21
pubmed: 26272040
BMJ. 2020 Feb 19;368:m606
pubmed: 32075786
Biosci Trends. 2020 Mar 16;14(1):69-71
pubmed: 31996494
Viruses. 2020 Feb 22;12(2):
pubmed: 32098422
Lancet. 2020 Feb 29;395(10225):687
pubmed: 32059798
Trends Pharmacol Sci. 2020 Jun;41(6):363-382
pubmed: 32291112
Lancet Respir Med. 2015 Jan;3(1):24-32
pubmed: 25529339
Nat Rev Drug Discov. 2020 Mar;19(3):149-150
pubmed: 32127666
Biomed Chromatogr. 2009 Apr;23(4):371-81
pubmed: 18937306
Sci China Life Sci. 2020 May;63(5):706-711
pubmed: 32146694
Transfusion. 2010 Sep;50(9):1967-71
pubmed: 20412524
Nat Rev Immunol. 2020 May;20(5):269-270
pubmed: 32273594
J Virol. 2005 Sep;79(17):11062-70
pubmed: 16103157
Virol J. 2005 Aug 22;2:69
pubmed: 16115318
Nat Commun. 2020 Jan 10;11(1):222
pubmed: 31924756
JAMA. 2020 Apr 21;323(15):1488-1494
pubmed: 32125362
Toxicol Rep. 2020 Apr 30;7:658-663
pubmed: 32355638
Drugs. 2014 Feb;74(2):195-206
pubmed: 24343782
J Theor Biol. 2008 Oct 21;254(4):861-7
pubmed: 18706430
Lancet. 2020 Feb 15;395(10223):473-475
pubmed: 32043983
Curr Med Chem. 2008;15(10):997-1005
pubmed: 18393857
PLoS One. 2014 Aug 21;9(8):e105617
pubmed: 25144636
Comput Struct Biotechnol J. 2020 Mar 30;18:784-790
pubmed: 32280433
Ann Intern Med. 2015 Oct 6;163(7):519-28
pubmed: 26258555
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Curr Top Med Chem. 2020;20(8):603-605
pubmed: 32133962
JAMA. 2020 Apr 21;323(15):1502-1503
pubmed: 32105304

Auteurs

Yongtao Duan (Y)

Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou University, Zhengzhou 450001, China.

Yongfang Yao (Y)

School of Pharmaceutical Science, Zhengzhou University, Zhengzhou, Henan 450001, China.

Senthil Arun Kumar (SA)

Department of Endocrinology and Metabolism, Genetics, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou University, Zhengzhou 450001, China.

Hai-Liang Zhu (HL)

Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou University, Zhengzhou 450001, China; State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, China. Electronic address: zhuhl@nju.edu.cn.

Junbiao Chang (J)

School of Pharmaceutical Science, Zhengzhou University, Zhengzhou, Henan 450001, China. Electronic address: changjunbiao@zzu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH